Publications by authors named "Gutschi L"
Article Synopsis
- Two patients with type 2 diabetes experienced significantly low HDL-C levels while undergoing treatment with rosiglitazone, with one seeing a drop from 33 to 11.6 mg/dL and the other from 44.8 to 19.7 mg/dL.
- Both patients had their low HDL-C levels resolve after stopping rosiglitazone and showed no such changes when treated with pioglitazone, indicating a specific association with rosiglitazone therapy.
- It is suggested that monitoring of lipid levels should be conducted for patients on rosiglitazone since paradoxical decreases in HDL-C have been reported, further supporting the need to assess lipid changes regularly during long-term treatment.
This study was performed to evaluate the use of antidepressant medications among Canadian Forces (CF) members. A retrospective chart review was undertaken at seven CF bases for members who received antidepressant medications during a 6-month period. Data were collected on doses, duration, and types of antidepressant drugs, indications for therapy, and prescriber characteristics.
View Article and Find Full Text PDF